___

• Williams JT, Southerland SS, Souza J. Cells isolated from adult human skeletal musclecapable of differentiating into multiple mesodermal phenotypes. Am Surg. 1999;65:22–6.
• Galmiche MC, Koteliansky VE, Briere J. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood. 1993;82:66–76.
• Theise ND, Nimmakayalu M, Gardner R. Liver from bone marrow in humans. Hepatology. 2000;32:11–6.
• Theise ND, Badve S, Saxena R. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology. 2000;31:235–40.
• Orlic D, Kajstura J, Chimenti S. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–5.
• Wu GD, Nolta JA, Jin YS. Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation. 2003;75:679–85.
• Davidoff AM, Ng CY, Brown P. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growthin mice. Clin Cancer Res. 2001;7:2870–9.
• Crisa L, Cirulli V, Smith KA. Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. Blood. 199;94:3928–40.
• Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 2004;287:2670-6.
• Huang W, Mo X, Qin C, Zheng J, Liang Z, Zhang C. Transplantation of differentiated bone marrow stromal cells promotes motor functional recovery in rats with stroke. Neurol Res.2013; 35:320-8.
• Murphy JM, Fink DJ, Hunziker EB. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. 2003;48:3464–74.
• Das AK. Stem cell therapy for critical limb ischaemia. Indian J Surg. 2009;71:177-81.
• Hess DC, Borlongan CV. Stem cells and neurological diseases. Cell Prolif. 2008;1:94-114.
• Brockes JP. Amphibian limb regeneration: rebuilding a complex structure. Science. 1997;276:81– 7.
• Brockes JP, Kumar A. Appendage regeneration in adult vertebrates and implications for regenerative medicine. Science. 2005; 310:1919–23.
• Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA et al. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4:1313–7.
• Munoz JR,Stoutenger BR, Robinson AP. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci. 2005;102:18171–6.
• Magavi SS, Leavitt BR, Macklis JD. Induction of neurogenesis in the neocortex of adult mice. Nature.2000;405: 951–5.
• Johansson CB. Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat Cell Biol. 2008;10:575–83.
• Nygren JM. Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat Cell Biol.2000;10:584–92.
• Singec I,Snyder EY. Inflammation as a matchmaker: revisiting cell fusion. Nat Cell Biol. 2008;10:503–5.
• Neirinckx V, Cantinieaux D, Coste C, Rogister B, Franzen R, Wislet-Gendebien S. Spinal cord injuries - how could adult mesenchymal and neural crest stem cells take up the challenge?. Stem Cells. 2014;32:829-43..
• Cogle CR. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet. 2004;363: 1432–7.
• Weimann JM, Charlton CA, Brazelton TR, Hackman RC, Blau HM. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci. 2003;18 2088- 93.
• Sensebé L, Bourin P, Tarte K. Good manufacturing practices production of mesenchymal stem/stromal cells. Phil Trans R Soc. 2006;361: 1463–75.
• Wang T, Tang W, Sun S, Xu T, Wang H, Guan J et al. Intravenous infusion of bone marrow mesenchymal stem cells improves brain function after resuscitation from cardiac arrest. Crit Care Med. 2008;36:486-91.
• Chung DJ, Choi CB, Lee SH, Kang EH, Lee JH, Hwang SH et al. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J Neurosci Res. 2009;87:3554-67.
• Harris VK, Yan QJ, Vyshkina T, Sahabi S, Liu X, Sadiq SA. Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural pogenitors in an experimental model of multiple sclerosis. J Neurol Sci. 2012;15,313:167-77.
• Sokolova IB, Sergeev IV, Bilibina AA, Dvoretskiy DP. Arteriogenesis in the pia matter of the rat brain cortex after intracerebral injection of mesenchymal stem cells. Bull Exp Biol Med. 2012;154:177-9.
• Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N et al. Stem cell treatment in Amyotrophic Lateral Sclerosis. J Neurol Sci. 2008;15,265:78-83.
• Kessler JA. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature. 1993;362:62.
• Croitoru-Lamoury J, Lamoury FM, Zaunders JJ, Veas LA, Brew BJ. Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone. Cytokine Res. 2007;27:53-64.
• Kang KS, Kim S, Oh YH. A 37-year old spinal cord-injured female patient, transplanted of multi- potent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy. 2005;7:368-73.
• Cristofanilli M, Harris VK, Zigelbaum A, Goossens AM, Lu A, Rosenthal H et al. Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice. Stem Cells. 2011;20:2065-76.
• Rao SS, Hofmann LA, Shakil A. Parkinson's disease: diagnosis and treatment Am Fam Physician. 2006; 15,74:2046-54.
• Keitel A, Ferrea S, Südmeyer M, Schnitzler A, Wojteck L. Expectation modulates the effect of deep brain stimulation on motor and cognitive function in tremor-dominant Parkinson's disease. PLoS One. 2013;2:8-12.
• Ryu MY, Lee MA, Ahn JH, Cho KG, Kim SU.Brain transplantation of genetically modified neural stem cells in parkinsonian rat. Cell Transplant. 2005;14:193–202.
• Kim SU, Park IH, Kim TH. Brain transplantationof human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase-1 provides functional improvement in animal models of Parkinson disease. Neuropathology. 2006;26:129–40.
• Kim JH, Auerbach JM, Rodríguez-Gómez JA, Velasco I, Gavin D, Lumelsky N et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature. 2002;4:50-6.
• Kriks S, Shim JW, Piao J, Ganat YM, Wakeman DR, Xie Z et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature. 2011;6,480:547-51.
• Fricker-Gates RA, Gates MA. Stem cell-derived dopamine neurons for brain repair in Parkinson's diseases. Regen Med. 2010;5:267-78.
• Studer L. Derivation of dopaminergic neurons from pluripotent stem cells. Prog Brain Res. 2012;200:243–63.
• Yang B, Strong R, Sharma S, Brenneman M, Mallikarjunarao K, Xi X et al. Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res. 2011;89:833–9.
• Engelhardt B, Sorokin L. The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol. 2009;31:497–511.
• Redzic Z. Molecular biology of the blood–brain and the blood–cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS. 2011;8:3.
• Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nature Biotechnol. 2002;20:1103–10.
• Guo J, Zeng Y, Liang Y, Wang L, Su H, Wu W. Cyclosporine affects the proliferation and differentiation of neural stem cells in culture. Neuroreport. 2007;18:863–8.
• Moloney TC, Rooney GE, Barry FP, Howard L, Dowd E. Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain. Brain Res. 2010;1359:33-43.
• Rowland LP. Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688–1700.
• Boillee S, Van de Velde C, Cleveland DW. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006;52:39–59.
• Traub R, Mitsumoto H, Rowland L. Research advances in amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep. 2011;11:67–77.
• Kim SU, de Vellis J. Stem cell-based cell therapy in neurological diseases: areview. J Neurosci Res. 2009;87:2183–200.
• Lunn JS, Sakowski SA, Federici T. Stem cell technology for the study andtreatment of motor neuron diseases. Regen Med. 2011;6:201–13.
• Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient’s bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol. 2007;211:27–35.
• Chi L, Ke Y, Luo C. Motor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice. Stem Cells. 2006;24:34–43.
• Mazzini L, Vercelli A, Ferrero I. Stem cells in amyotrophic lateral sclerosis:state of the art. Expert Opin Biol Ther. 2009;9:1245–58.
• Klein SM, Behrstock S, McHugh J, Hoffmann K, Wallace K, Suzuki M et al. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther. 2005;16:509-21.
• Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci. 2005;8:85-92.
• Mazzini L, Mareschi K, Ferrero I, Miglioretti M, Stecco A, Servo Set al. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study. Cytotherapy. 2012;14:56-60.
• O'Shea B. A review of Huntington's disease. Int J Psychiatry Clin Pract. 1997;1:135-40.
• Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J et all. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington’s disease. Mol Neurobiol. 2012;45: 87-98.
• Baquet ZC, Gorski JA, Jones KR. Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brainderived neurotrophic factor. J Neurosci. 2004;24:4250-8.
• Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J et al. Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington’s disease. Behav Brain Res. 2010;214:193-200.
• Ryu JK, Kim J, Cho SJ, Hatori K, Nagai A, Choi HBet al. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease. Neurobiol Dis. 2004;16:68-77.
• Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–59.
• Wenk GL. Neuropathologic changes in Alzheimer’s disease. J Clin Psychiatry. 2003;64:7–10.
• Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982;217:408-14.
• Pohanka M. Cholinesterases, a target of pharmacology and toxicology. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155:219–23.
• Haas C. Strategies, development, and pitfalls of therapeutic options for Alzheimer’s disease. J Alzheimers Dis. 2012;28:241–81.
• Phinney DG, Prockop DJ. Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair—Current views. Stem Cells. 2007;25:2896–2902.
• Yang H, Xie Z, Wei L, Yang H, Yang S, Zhu Z et al. Human umbilical cord mesenchymal stem cell- derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model. Stem Cell Res Ther. 2013;4:76.
• Mitran SI, Catalin B, Sfredel V, Balseanu TA. Neuroregeneration and dementia: new treatment options. J Mol Psychiatry. 2013;1:1–6.
• Musiał A, Bajda M, Malawska B. Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment. Curr Med Chem. 2007;14:2654-79.
• Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller FJ, Loring JF et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A. 2009;106: 13594-9.
• Kim KS, Kim HS, Park JM, Kim HW, Park MK, Lee HSet al. Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer’s disease model. Neurobiol Aging. 2013;34:2408–20.
• Bae JS, Jin HK, Lee JK, Richardson JC, Carter JE. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease. Curr Alzheimer Res. 2013;10:524-31.
• Khairallah MI, Kassem LA, Yassin NA, El Din MA, Zekri M, Attia M. The hematopoietic growth factor "erythropoietin" enhances the therapeutic effect of mesenchymal stem cells in Alzheimer's disease. Pak J Biol Sci. 2014;17:9-21.
• Correspondence Address / Yazışma Adresi Olcay Kıroğlu
• Çukurova Üniversitesi Tıp Fakültesi
• Farmakoloji Anabilim Dalı Adana,Turkey
• e-mail: okiroglu@cu.edu.tr